237 related articles for article (PubMed ID: 9681985)
1. Development of in vitro peptide substrates for human rhinovirus-14 2A protease.
Wang QM; Johnson RB; Sommergruber W; Shepherd TA
Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985
[TBL] [Abstract][Full Text] [Related]
2. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates.
Wang QM; Sommergruber W; Johnson RB
Biochem Biophys Res Commun; 1997 Jun; 235(3):562-6. PubMed ID: 9207196
[TBL] [Abstract][Full Text] [Related]
3. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates.
Wang QM; Johnson RB; Cox GA; Villarreal EC; Loncharich RJ
Anal Biochem; 1997 Oct; 252(2):238-45. PubMed ID: 9344409
[TBL] [Abstract][Full Text] [Related]
4. Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli.
Birch GM; Black T; Malcolm SK; Lai MT; Zimmerman RE; Jaskunas SR
Protein Expr Purif; 1995 Oct; 6(5):609-18. PubMed ID: 8535153
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
6. Activation of human rhinovirus-14 3C protease.
Wang QM; Johnson RB
Virology; 2001 Feb; 280(1):80-6. PubMed ID: 11162821
[TBL] [Abstract][Full Text] [Related]
7. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A.
Sommergruber W; Ahorn H; Zöphel A; Maurer-Fogy I; Fessl F; Schnorrenberg G; Liebig HD; Blaas D; Kuechler E; Skern T
J Biol Chem; 1992 Nov; 267(31):22639-44. PubMed ID: 1331062
[TBL] [Abstract][Full Text] [Related]
8. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.
Cordingley MG; Callahan PL; Sardana VV; Garsky VM; Colonno RJ
J Biol Chem; 1990 Jun; 265(16):9062-5. PubMed ID: 2160953
[TBL] [Abstract][Full Text] [Related]
9. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison.
Bjorndahl TC; Andrew LC; Semenchenko V; Wishart DS
Biochemistry; 2007 Nov; 46(45):12945-58. PubMed ID: 17944485
[TBL] [Abstract][Full Text] [Related]
10. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.
Webber SE; Okano K; Little TL; Reich SH; Xin Y; Fuhrman SA; Matthews DA; Love RA; Hendrickson TF; Patick AK; Meador JW; Ferre RA; Brown EL; Ford CE; Binford SL; Worland ST
J Med Chem; 1998 Jul; 41(15):2786-805. PubMed ID: 9667969
[TBL] [Abstract][Full Text] [Related]
11. Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues.
Neubauer D; Aumayr M; Gösler I; Skern T
J Gen Virol; 2013 Jul; 94(Pt 7):1535-1546. PubMed ID: 23580429
[TBL] [Abstract][Full Text] [Related]
12. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
[TBL] [Abstract][Full Text] [Related]
13. The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis.
Petersen JF; Cherney MM; Liebig HD; Skern T; Kuechler E; James MN
EMBO J; 1999 Oct; 18(20):5463-75. PubMed ID: 10523291
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase.
Davis GJ; Wang QM; Cox GA; Johnson RB; Wakulchik M; Dotson CA; Villarreal EC
Arch Biochem Biophys; 1997 Oct; 346(1):125-30. PubMed ID: 9328292
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
[TBL] [Abstract][Full Text] [Related]
16. Proteolytically active 2A proteinase of human rhinovirus 2 is toxic for Saccharomyces cerevisiae but does not cleave the homologues of eIF-4 gamma in vivo or in vitro.
Klump H; Auer H; Liebig HD; Kuechler E; Skern T
Virology; 1996 Jun; 220(1):109-18. PubMed ID: 8659103
[TBL] [Abstract][Full Text] [Related]
17. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli.
Wang QM; Johnson RB; Cox GA; Villarreal EC; Churgay LM; Hale JE
J Virol; 1998 Feb; 72(2):1683-7. PubMed ID: 9445078
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
20. Substrates and inhibitors of human T-cell leukemia virus type I protease.
Ding YS; Rich DH; Ikeda RA
Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
